SEARCH

SEARCH BY CITATION

References

  • Anderson, P.M., Ramsay, N.K., Shu, X.O., Rydholm, N., Rogosheske, J., Nicklow, R., Weisdorf, D.J. & Skubitz, K.M. (1998) Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant, 22, 339344.
  • Bearman, S.I., Petersen, F.B., Schor, R.A., Denney, J.D., Fisher, L.D., Appelbaum, F.R. & Buckner, C.D. (1990) Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant, 5, 173177.
  • Bierman, P.J., Bagin, R.G., Jagannath, S., Vose, J.M., Spitzer, G., Kessinger, A., Dicke, K.A. & Armitage, J.O. (1993) High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients. Annals of Oncology, 4, 767773.
  • Bolwell, B.J., Kalaycio, M., Sobecks, R., Andresen, S., Kuczkowski, E., Bernhard, L., Lomax, R., Kohuth, J., Mendiola, S., Rybicki, L. & Pohlman, B. (2002) A multivariate analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplantation, 30, 587591.
  • Cahn, J.Y., Labopin, M., Mandelli, F., Goldstone, A.H., Eberhardt, K., Reiffers, J., Ferrant, A., Franklin, I., Herve, P., Gratwohl, A. & Gorin, N.C. (1995) Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group. Blood, 85, 575579.
  • Carella, A., Carlier, P., Congiu, A., Occhini, D., Meloni, G., Aneselmo, A.P., Mandelli, F., Mazza, P., Tura, S. & Mangoni, L. (1991) Nine years’ experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report. Leukemia, 5(Suppl. 1), 6871.
  • Copelan, E., Bolwell, B., Lazarus, H., Harris, R., Herzig, R., Sigmund, D., Shurin, S., Grovas, A., Yanes, B., Koufos, A. & Bohnengel, A. (1996) Analysis of age as a predictor of survival following allogeneic and autologous marrow transplantation. Proceedings of the American Society of Clinical Oncology, 15, 84 (abstract).
  • Doney, K., Hagglund, H., Leisenring, W., Chauncey, T., Appelbaum, F.R. & Storb, R. (2003) Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biology of Blood and Marrow Transplant, 9, 472481.
  • Fujimaki, K., Maruta, A., Yoshida, M., Sakai, R., Tanabe, J., Koharazawa, H., Kodama, F., Asahina, S., Minamizawa, M., Matsuzaki, M., Fujisawa, S., Kanamori, H. & Ishigatsubo, Y. (2001) Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant, 27, 307310.
  • Giles, F.J., Redman, R., Yazji, S. & Bellm, L. (2002) Iseganan HCl: a novel antimicrobial agent. Expert Opinion on Investigational Drugs, 11, 11611170.
  • Giles, F.J., Miller, C.B., Hurd, D.D., Wingard, J.R., Fleming, T.R., Sonis, S.T., Bradford, W.Z., Pulliam, J.G., Anaissie, E.J., Beveridge, R.A., Brunvand, M.M. & Martin, P.J. (2003) A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial). Leukemia and Lymphoma, 44, 11651172.
  • Gordon, B., Spadinger, A., Hodges, E., Ruby, E., Stanley, R. & Coccia, P. (1994) Effect of granulocyte- macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 12, 19171922.
  • Greinix, H.T., Nachbaur, D., Krieger, O., Eibl, M., Knobl, P., Kalhs, P., Lutz, D., Linkesch, W., Niederweiser, D., Hinterberger, W., Lechner, K., Rosenmayr, A. & Gritsch, B. (2002) Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry. British Journal of Haematology, 117, 914923.
  • Hertenstein, B., Stefanic, M., Schmeiser, T., Scholz, M., Goller, V., Clausen, M., Bunjes, D., Wiesneth, M., Novotny, J. & Kochs, M. (1994) Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. Journal of Clinical Oncology, 12, 9981004.
  • Jain, B., Floreani, A.A., Anderson, J.R., Vose, J.M., Robbins, R.A., Rennaed, S.I. & Sisson, J.H. (1996) Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group. Bone Marrow Transplant, 17, 561568.
  • Kusnierz-Glaz, C.R., Schlegel, P.G., Wong, R.M., Schriber, J.R., Chao, N.J., Amylon, M.D., Hu, W.W., Negrin, R.S., Lee, Y., Blume, K.G. & Long, G.D. (1997) Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. Journal of Clinical Oncology, 15, 1825.
  • Lazarus, H.M. & Nugent, M. (1996) Outcome of autotransplants in older adults. Proceeding of the American Society of Clinical Oncology, 15, 338 (abstract).
  • Miller, C.B., Piantadosi, S., Vogelsang, G.B., Marcellus, D.C., Grochow, L., Kennedy, M.J. & Jones, R.J. (1996) Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. Journal of Clinical Oncology, 14, 13271332.
  • Rapoport, A.P., Miller Watelet, L.F., Linder, T., Eberly, S., Raubertas, R.F., Lipp, J., Duerst, R., Abboud, C.N., Constine, L., Andrews, J., Etter, M.A., Spear, L., Powley, E., Packman, C.H., Rowe, J.M., Schwertschlag, U., Bedrosian, C. & Liesveld, J.L. (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. Journal of Clinical Oncology, 17, 24462453.
  • Sezer, O., Eucker, J., Metzner, B., Wattad, M., Fuss, H., Bauhuis, C., Heit, W., Schultze, W., Illiger, H. & Possinger, K. (2000) Mucositis is associated with increased rate of documented infections and treatment related mortality after high-dose therapy with autologous peripheral stem-cell transplantation. Proceedings of the American Society of Clinical Oncology, 19, 216 (abstract).
  • Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M. & Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 42264235.
  • Sonis, S.T. (2004) Oral mucositis in cancer therapy. Journal of Supportive Oncology, 2, 38.
  • Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett, W.H., Mulagha, M.T., Peterson, D.E., Rose, A.H., Schubert, M.M., Spijkervet, F.K. & Wittes, J.P. (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer, 85, 21032113.
  • Sonis, S.T., Oster, G., Fuchs, H., Bellm, L., Bradford, W.Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J.B., LeVeque, F.G., Miller, C., Peterson, D.E., Schubert, M.M., Spikervet, F.K. & Horowitz, M. (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 19, 22012205.
  • Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., McCarty, J., LeMaistre, C.F., Sung, E.C., Blazar, B.R., Elhardt, D., Chen, M.G. & Emmanouilides, C. (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine, 351, 25902598.
  • Sweetenham, J.W., Pearce, R., Philip, T., Proctor, S.J., Mandelli, F., Colombat, P. & Goldstone, A.H. (1994) High-dose therapy and autologous bone marrow transplantation for intermediate and high grade non-Hodgkin's lymphoma in patients aged 55 years and over: results from the European Group for Bone Marrow Transplantation. The EBMT Lymphoma Working Party. Bone Marrow Transplant, 14, 981987.
  • Weisdorf, D.J., Bostrom, B., Raether, D., Mattingly, M., Walker, P., Pihlstrom, B., Ferrieri, P., Haake, R., Goldman, A. & Woods, W. (1989) Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Bone Marrow Transplant, 4, 8995.
  • Zangari, M., Henzlova, M.J., Ahmad, S., Scigliano, E., Isola, L., Platnik, J., Croft, L.B., Sandler, D., Diamond, J.A., Machac, J. & Fruchtman, S.M. (1999) Predictive value of left ventricular ejection fraction in stem cell transplantation. Bone Marrow Transplant, 23, 917920.
  • Ziegler, T.R., Young, L.S., Benfell, K., Scheltinga, M., Hortos, K., Bye, R., Morrow, F.D., Jacobs, D.O., Smith, R.J. & Antin, J.H. (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Annals of Internal Medicine, 116, 821828.